Clinical Effects of BNT162b2 Vaccine on the Short-Term Course of Chronic Spontaneous Urticaria Patients

BACKGROUND: The clinical effects of Pfizer-BioNTech coronavirus disease 2019 (COVID-19; BNT162b2) vaccine on the clinical course of chronic spontaneous urticaria (CSU) is unclear. AIMS AND OBJECTIVES: To evaluate the clinical effects of BNT162b2 vaccine on the clinical course of CSU. METHODS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuzer, Can, Sezer, Suat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043695/
https://www.ncbi.nlm.nih.gov/pubmed/36998869
http://dx.doi.org/10.4103/ijd.ijd_543_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043695/
https://www.ncbi.nlm.nih.gov/pubmed/36998869
http://dx.doi.org/10.4103/ijd.ijd_543_22

Ejemplares similares